Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Tax Provisions: 2009-2024

Historic Tax Provisions for Ironwood Pharmaceuticals (IRWD) over the last 8 years, with Dec 2024 value amounting to $64.3 million.

  • Ironwood Pharmaceuticals' Tax Provisions rose 103.60% to $27.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.0 million, marking a year-over-year decrease of 12.97%. This contributed to the annual value of $64.3 million for FY2024, which is 22.97% down from last year.
  • As of FY2024, Ironwood Pharmaceuticals' Tax Provisions stood at $64.3 million, which was down 22.97% from $83.5 million recorded in FY2023.
  • Ironwood Pharmaceuticals' 5-year Tax Provisions high stood at $83.5 million for FY2023, and its period low was -$327.8 million during FY2021.
  • Its 3-year average for Tax Provisions is $75.1 million, with a median of $77.4 million in 2022.
  • In the last 5 years, Ironwood Pharmaceuticals' Tax Provisions plummeted by 12,240.74% in 2021 and then soared by 123.61% in 2022.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' Tax Provisions stood at $2.7 million in 2020, then tumbled by 12,240.74% to -$327.8 million in 2021, then spiked by 123.61% to $77.4 million in 2022, then rose by 7.88% to $83.5 million in 2023, then decreased by 22.97% to $64.3 million in 2024.